Abstract
Small molecules remain the backbone for modern drug discovery. They are conceived and synthesized by medicinal chemists, many of whom were originally trained as organic chemists. Support from government and industry to provide training and personnel for continued development of this critical skill set has been declining for many years. This Viewpoint highlights the value of organic chemistry and organic medicinal chemists in the complex journey of drug discovery as a reminder that basic science support must be restored.
Original language | English |
---|---|
Pages (from-to) | 1315-1316 |
Number of pages | 2 |
Journal | ACS Chemical Neuroscience |
Volume | 7 |
Issue number | 10 |
DOIs | |
State | Published - 19 Oct 2016 |
Keywords
- AZT
- drug discovery
- organic chemistry
- small molecules